When was IRIDEX founded?

IRIDEX was founded in 1989 and raised its 1st funding round 36 years after it was founded.

Where is IRIDEX located?

IRIDEX is headquartered in Mountain View, United States. It is registered at Mountain View, California.

How many employees does IRIDEX have?

As of Aug 31, 2026, the latest employee count at IRIDEX is 182.

Is IRIDEX a funded company?

IRIDEX is a funded company, having raised a total of $***** in its 1st and only funding round, a Post IPO round on Mar 19, 2025.

When was the latest funding round of IRIDEX?

IRIDEX's latest funding was a $***** Post IPO round on Mar 19, 2025, with participation from 0 investor.

What is the annual revenue of IRIDEX?

Annual revenue of IRIDEX is between $50M and $100M as on Jan 03, 2026

Where does IRIDEX rank among its competitors?

IRIDEX ranks 2nd amongst 76 active competitors, of which 10 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was IRIDEX, which secured $10M in Mar, 2025.

Who are the top competitors of IRIDEX?

IRIDEX's top competitors include Perfuse Therapeutics, MicroSurgical Technology and Dopavision. Among them, IRIDEX secured the most recent funding round in March, 2025.

IRIDEX - 2026 Company Profile, Funding, Competitors & Financials

IRIDEX is a public company based in Mountain View (United States), founded in 1989. It operates as a Manufacturer of ophthalmic laser systems and surgical instruments for eyes. IRIDEX has raised an undisclosed amount in funding. The company has 76 active competitors, including 10 funded and 19 that have exited. Its top competitors include companies like Perfuse Therapeutics, MicroSurgical Technology and Dopavision.

Company Details

Manufacturer of ophthalmic laser systems and surgical instruments for eyes. These medical devices support the treatment of retinal diseases and glaucoma through traditional and tissue-sparing laser technology. The product portfolio includes delivery devices, endoscopic probes, and consumables designed for use in office settings and surgical facilities.

Website: iridex.com
Social
Email ID: *****@iridex.com
Phone Number: +1 **********
Registered Address: Mountain View, California

Key Metrics

Founded Year

1989

Location

Mountain View, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 19, 2025, $*****

Investors

Incubic & 2 more

Ranked

2^nd among 76 active competitors

Annual Revenue

$50M - $100M as on Jan 03, 2026

Employee Count

182 as on Aug 31, 2026

Similar Companies

Perfuse Therapeutics & 86 more

Exit Details

Public

View IRIDEX's full profile

IRIDEX is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
IRIDEX CORP CIN: 1006045 , United States, Active	Nov 20, 1995	$50M - $100M (As on Jan 03, 2026)	130 (As on Dec 31, 2022)	-
Iridex Corporation CIN: 770210467 , United States, Active	Dec 26, 999	-	104 (As on Dec 31, 2024)	-

IRIDEX got listed on Feb 15, 1996.

Click here to take a look at IRIDEX's IPO in detail

IRIDEX has raised funding over 1 round. IRIDEX has 3 institutional investors.

Here is the list of recent funding rounds of IRIDEX:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 19, 2025	9766600	Post IPO	2237170	7653014	5487111	7697045

Access funding benchmarks and valuations. Sign up today!

View details of IRIDEX's funding rounds and investors

IRIDEX's employee count trend

IRIDEX has 182 employees as of Aug 26. Here is IRIDEX's employee count trend over the years:

Uncover IRIDEX's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of IRIDEX include Perfuse Therapeutics, MicroSurgical Technology and Dopavision. Here is the list of Top 10 competitors of IRIDEX, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Perfuse Therapeutics 2018, San Francisco (United States), Acquired	Developer of therapies to treat eye disorders	-	Access Industries, Lilly Asia Ventures & 3 others	49/100
2nd	IRIDEX 1989, Mountain View (United States), Public	Manufacturer of ophthalmic laser systems and surgical instruments for eyes	-	Incubic, Technology Partners & 1 others	48/100
3rd	MicroSurgical Technology 1976, Redmond (United States), Acquired	Develops a portfolio of Surgical tools for Ophthalmic surgeries	-	-	47/100
4th	Dopavision 2017, Berlin (Germany), Series A	Developer of a digital therapeutic for myopia	$17.4M	Boehringer Ingelheim Venture Fund, Seventure Partners ... & 9 others	45/100
5th	Oertli Instrumente 1955, Berneck (Switzerland), Unfunded	Developer of ophthalmology medical device	-	-	44/100
6th	Keeler 1917, Windsor (United Kingdom), Unfunded	A portfolio of ophthalmic devices	-	-	44/100
7th	Lalji International 2018, Ahmedabad (India), Unfunded	Manufacturer of disposable medical drapes and surgical gowns. The company produces a variety of products for various medical applications, including ophthalmology, gynecology, and general surgery. These products are designed for single-use and contribute to maintaining a sterile environment during procedures. The manufacturing process emphasizes quality control to ensure the safety and efficacy of the products. The company's offerings also include hospital beds and related furniture.	-	-	42/100
8th	Lamellar 2007, Glasgow (United Kingdom), Series C	Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies	$18.4M	Hambro Perks, Invesco & 4 others	42/100
9th	Ziemer Ophthalmology 2005, Basel (Switzerland), Series B	Portfolio of devices for refractive and corneal surgery	$17.4M	BV Partners, HBM Partners & 1 others	40/100
10th	Katena 1975, Tampa (United States), Acquired	Ophthalmic surgical products for sight restoration, clinician support, and patient care	$7.5M	Audax Private Equity	40/100